This event will highlight and discuss recent advances in strategies for controlling stem cell fate and reprogramming. Progress towards therapeutic applications, and new insights into the molecular basis of pluripotency, differentiation, and transdifferentiation will be discussed in an informal setting with plenty of opportunity for networking. This event has CPD accreditation. This event is part of The 2014 Tissue Engineering Congress.